/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

Z

Zhuoran Yao

Sichuan University(CN)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

50

Papers

1.3K

Citations

11

h-index

12

i10-index

Zhuoran Yao is an academic researcher from Sichuan University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Lung Cancer Research Studies. The author has an h-index of 11, co-authored 43 publications.

ORCID: 0000-0002-1755-3563

Research Topics

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations

Papers by this author

works

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis

2020 · BMC Medicine · 327 citations

https://doi.org/10.1186/s12916-020-01549-2

Xiaoxiang Zhou Zhuoran Yao Huaxia Yang Naixin Liang

Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis

2024 · Nature Communications · 29 citations

https://doi.org/10.1038/s41467-024-46195-x

Ziyue Zhou Xiaoxiang Zhou Xu Jiang Bo Yang

Successful Pregnancy and Healthy Baby Outcome in a Patient With Tyrosine Kinase Inhibitor–Refractory ALK-Positive NSCLC and Central Nervous System Metastasis Treated With Lorlatinib With Maternal-Fetal Pharmacokinetics and Child Milestone Development Correlations

2025 · Journal of Thoracic Oncology · 1 citations

https://doi.org/10.1016/j.jtho.2025.05.017

Zhuoran Yao Min Tang Ying Jin Jie Ruan

Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naive Stage IV PD-L1<sup>+</sup> Non-Small-Cell Lung Cancer Patients

2024 · 0 citations

https://doi.org/10.1158/1078-0432.27034243

Xiaojuan Zhou Laiyan Zhou Zhuoran Yao Meijuan Huang

Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naive Stage IV PD-L1<sup>+</sup> Non-Small-Cell Lung Cancer Patients

2024 · 0 citations

https://doi.org/10.1158/1078-0432.27034243.v1

Xiaojuan Zhou Laiyan Zhou Zhuoran Yao Meijuan Huang

Nervous system contributions to small cell lung cancer: Lessons from diverse oncological studies

2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 0 citations

https://doi.org/10.1016/j.bbcan.2024.189252

Shuangsi Liao Kai Kang Zhuoran Yao You Lü

Research topics

topics

Cancer Immunotherapy and Biomarkers

CAR-T cell therapy research

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Lung Cancer Treatments and Mutations

Chat about Author

Papers

Chat

Click to start Chat